| abstract |
A release rate profile for a pseudoephedrine component is achieved over a long period of time exceeding 12 hours and preferably at least 16 hours while maintaining effective once-daily dose desloratadine delivery. (A) a core comprising an effective amount of pseudoephedrine or a pharmaceutically acceptable salt thereof; and (b) a film coating comprising uniformly covering the core and comprising an effective amount of desloratadine. A film-coated extended release solid oral dosage composition comprising: [Selection figure] None |